DGX - Quest Diagnostics Inc

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Quest Diagnostics Non-GAAP EPS of $2.30 beats by $0.04, revenue of $2.34B beats by $90M
• Quest Diagnostics Q2 2023 Earnings Preview
• Quest closes on merger with Haystack Oncology, deal worth up to $450M
• FDA to more closely regulate lab-developed tests – WSJ
• Quest Diagnostics declares $0.71 dividend
• Quest Diagnostics downgraded to neutral at BofA on lower FY 2023-25 estimates
• Quest to acquire cancer detection test maker Haystack in all cash deal
• Quest Diagnostics Non-GAAP EPS of $2.04 beats by $0.07, revenue of $2.33B beats by $130M
• Quest Diagnostics Q1 2023 Earnings Preview
• Quest Diagnostics upgraded to neutral at Citi on current valuation
• Quest Diagnostics elects CEO Davis as chairman
• Quest, Tower Health team up to provide laboratory services
• Quest Diagnostics slips as outlook disappoints amid hit to COVID-19 test revenue
• Quest Diagnostics Non-GAAP EPS of $1.98 beats by $0.08, revenue of $2.33B beats by $70M
• Quest Diagnostics raises dividend by 7.6% to $0.71, increases buyback authorization by $1B
• Quest Diagnostics Q4 2022 Earnings Preview
• Quest Diagnostics' unit Pack Health to expand Alabama facility
• Quest Diagnostics signs group purchasing agreement with Premier
• Quest Diagnostics downgraded to sell at Citi following recent stock upside
• Quest Diagnostics declares $0.66 dividend